Restenoses, Coronary Clinical Trial
Official title:
BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the SiroLimus Eluting Orsiro Stent Within Daily Clinical Practice in Small Vessels
Assessment of the clinical safety and performance of the Orsiro drug-eluting stent in a real world setting in patients with small vessels with reference vessel diameter ≤2.75 mm.
Prospective, single-arm, multi-center, all-comers registry with clinical follow-up visits at the hospital or by phone at 6 and 12 months post-procedure. A minimum of 1000 patients will be enrolled in approximately 15 sites in Brazil, including at least 415 patients with reference vessel diameter ≤2.75 mm as assessed by online QCA. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05544864 -
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
|
N/A | |
| Recruiting |
NCT04573660 -
Abbott Vascular Medical Device Registry
|
||
| Not yet recruiting |
NCT03588962 -
Metal Allergy In-Stent Restenosis Study
|
N/A |